MSI2 and lymphoma: Moreover, more than 2% of ~ 5000 samples from patients with haematopoietic and lymphoid cancers included in the COSMIC Release v94 database carried coding mutations in MYO9A, PALM2-AKAP2, MSI2 or CACNA1E (range 121–202 mutated samples per gene) (Supplementary Table S4).